Status:
COMPLETED
Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial
Lead Sponsor:
Kintampo Health Research Centre, Ghana
Collaborating Sponsors:
London School of Hygiene and Tropical Medicine
Conditions:
Malaria
Eligibility:
All Genders
Up to 48 years
Phase:
PHASE4
Brief Summary
Effective use of Rapid Diagnostic Test (RDT) and artemisinin-based combination therapy (ACT) depends on the accuracy and safety of RDT based treatment practices and on factors related to the health de...
Detailed Description
Two-stage, four component study Stage I - Component A: Accuracy of RDT and the outcome of treatment based on RDT results Primary outcome:What is the sensitivity and specificity of Paracheck cassettes ...
Eligibility Criteria
Inclusion
- All children aged less than 48mths reporting to health center with suspected malaria
Exclusion
- Children having chronic illnesses such as severe malnutrition and heart disease will be excluded from the study.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
3063 Patients enrolled
Trial Details
Trial ID
NCT00832754
Start Date
March 1 2009
End Date
December 1 2012
Last Update
December 21 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kintampo Health Research Center
Kintampo, BAR, Ghana, 200